ProEthic
Business Services · Alabama, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
530 Industrial Park Blvd, Montgomery, Al...Phone Number
(480) 725-8912Website
www.proethic.comRevenue
<$5 MillionIndustry
About ProEthic
ProEthic Org Chart
Is ProEthic your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
ProEthic, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on ProEthic recently announced quarterly report
Check out if ProEthic is spiking on competitors!
Click to see if ProEthic had a recent Job posting/layoffs
Product Launch: Get notified when ProEthic launches new products
Funding: Get notified immidiatlly once ProEthic has new funding data
Check if ProEthic has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at ProEthic
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined ProEthic as Masked Content
Find more new buyers
Compare Similar Companies to ProEthic
Compare insights from companies similar to ProEthic, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
ProEthic is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
ProEthic is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about ProEthic.
ProEthic Tech Stack
A closer look at the technologies used by ProEthic
ProEthic News & Media
CORRECTING and REPLACING Kowa Pharmaceuticals America, Inc. Receives Pediatric Indication and Six-Month Pediatric Exclusivity for LIVALO® (pitavastatin)
MONTGOMERY, Ala.--(BUSINESS WIRE)--Remove the three paragraphs with headings INDICATIONS AND USAGE, PRIMARY HYPERLIPIDEMIA AND MIXED DYSLIPIDEMIA, and LIMITATIONS OF USE from release issued June 18, 2019. The corrected release reads: KOWA PHARMACEUTICALS AMERICA, INC. RECEIVES PEDIATRIC INDICATION AND SIX-MONTH PEDIATRIC EXCLUSIVITY FOR LIVALO® (PITAVASTATIN) Kowa Pharmaceuticals America, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved the cholesterol-loweringKowa Pharmaceuticals America, Inc. Receives Pediatric Indication and Six-Month Pediatric Exclusivity for LIVALO® (pitavastatin)
MONTGOMERY, Ala.--(BUSINESS WIRE)--Kowa Pharmaceuticals America, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved the cholesterol-lowering drug LIVALO® (pitavastatin) for pediatric patients aged 8 years and older with heterozygous familial hypercholesterolemia (HeFH) to reduce elevated total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C) and apolipoprotein B (Apo B). The approval was granted in conjunction with fulfillment of FDA’s Written RequesKowa Pharmaceuticals America, Inc. Enters into Co-Promotion Agreement with Allergan for BYSTOLIC® (nebivolol) in the United States
MONTGOMERY, Ala.--(BUSINESS WIRE)--Kowa Pharmaceuticals America, Inc. announced today that it has entered into an agreement with Allergan plc. to co-promote Allergan’s BYSTOLIC® (nebivolol), a beta blocker approved for the treatment of hypertension to lower blood pressure, in the United States. Kowa’s nationwide sales force will co-promote BYSTOLIC to cardiologists and select primary care healthcare providers across the country along with the company’s cholesterol-lowering drug LIVALO® (pitavasKowa Pharmaceuticals America, Inc. Announces Appeals Court Decision Upholding Patent Protection for LIVALO® (pitavastatin)
MONTGOMERY, Ala.--(BUSINESS WIRE)--Kowa Pharmaceuticals America, Inc. announced today that the U.S. Court of Appeals for the Federal Circuit has affirmed the decision by the U.S. District Court for the Southern District of New York, upholding the validity of U.S. Patent No. 8,557,993 (the ‘993 patent) protecting the Company’s cholesterol-lowering drug LIVALO® (pitavastatin) tablets. This decision was the most recent in litigation involving challenges by eight generic companies to the patents pr
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding ProEthic
ProEthic is a Phoenix-based company specializing in commercial cleaning, janitorial, and landscaping services, emphasizing reliability and accountability. They offer a wide range of services including daily cleaning, office cleaning, glass cleaning, and landscape maintenance tailored to various industries such as general offices, car dealerships, a... Read More
